Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome

Qiwei Yang, Colleen M. Kiernan, Yufeng Tian, Helen R. Salwen, Alexandre Chlenski, Babette A. Brumback, Wendy B. London, Susan L. Cohn

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Purpose: Epigenetic aberrations have been shown to play an important role in the pathogenesis of most cancers. To investigate the clinical significance of epigenetic changes in neuroblastoma, we evaluated the relationship between clinicopathologic variables and the pattern of gene methylation in neuroblastoma cell lines and tumors. Experimental Design: Methylation-specific PCR was used to evaluate the gene methylation status of19 genes in14 neuroblastoma cell lines and 8 genes in 70 primary neuroblastoma tumors. Associations between gene methylation, established prognostic factors, and outcome were evaluated. Log-rank tests were used to identify the number of methylated genes that was most predictive of overall survival. Results: Epigenetic changes were detected in the neuroblastoma cell lines and primary tumors, although the pattern of methylation varied. Eight of the 19 genes analyzed were methylated in >70% of the cell lines. Epigenetic changes of four genes were detected in only small numbers of cell lines. None of the cell lines had methylation of the other seven genes analyzed. In primary neuroblastoma tumors, high-risk disease and poor outcome were associated with methylation of DCR2, CASP8, and HIN-1 individually. Although methylation of the other five individual genes was not predictive of poor outcome, a trend toward decreased survival was seen in patients with a methylation phenotype, defined as z4 methylated genes (P = 0.055). Conclusion: Our study indicates that clinically aggressive neuroblastoma tumors have aberrant methylation of multiple genes and provides a rationale for exploring treatment strategies that include demethylating agents.

Original languageEnglish (US)
Pages (from-to)3191-3197
Number of pages7
JournalClinical Cancer Research
Volume13
Issue number11
DOIs
StatePublished - Jun 1 2007

Fingerprint

Neuroblastoma
Methylation
Genes
Epigenomics
Cell Line
Tumor Cell Line
Neoplasms
Survival
Research Design
Phenotype
Polymerase Chain Reaction

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Yang, Q., Kiernan, C. M., Tian, Y., Salwen, H. R., Chlenski, A., Brumback, B. A., ... Cohn, S. L. (2007). Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome. Clinical Cancer Research, 13(11), 3191-3197. https://doi.org/10.1158/1078-0432.CCR-06-2846

Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome. / Yang, Qiwei; Kiernan, Colleen M.; Tian, Yufeng; Salwen, Helen R.; Chlenski, Alexandre; Brumback, Babette A.; London, Wendy B.; Cohn, Susan L.

In: Clinical Cancer Research, Vol. 13, No. 11, 01.06.2007, p. 3191-3197.

Research output: Contribution to journalArticle

Yang, Q, Kiernan, CM, Tian, Y, Salwen, HR, Chlenski, A, Brumback, BA, London, WB & Cohn, SL 2007, 'Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome', Clinical Cancer Research, vol. 13, no. 11, pp. 3191-3197. https://doi.org/10.1158/1078-0432.CCR-06-2846
Yang, Qiwei ; Kiernan, Colleen M. ; Tian, Yufeng ; Salwen, Helen R. ; Chlenski, Alexandre ; Brumback, Babette A. ; London, Wendy B. ; Cohn, Susan L. / Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome. In: Clinical Cancer Research. 2007 ; Vol. 13, No. 11. pp. 3191-3197.
@article{44658fde771f4a3382efe10dac59970e,
title = "Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome",
abstract = "Purpose: Epigenetic aberrations have been shown to play an important role in the pathogenesis of most cancers. To investigate the clinical significance of epigenetic changes in neuroblastoma, we evaluated the relationship between clinicopathologic variables and the pattern of gene methylation in neuroblastoma cell lines and tumors. Experimental Design: Methylation-specific PCR was used to evaluate the gene methylation status of19 genes in14 neuroblastoma cell lines and 8 genes in 70 primary neuroblastoma tumors. Associations between gene methylation, established prognostic factors, and outcome were evaluated. Log-rank tests were used to identify the number of methylated genes that was most predictive of overall survival. Results: Epigenetic changes were detected in the neuroblastoma cell lines and primary tumors, although the pattern of methylation varied. Eight of the 19 genes analyzed were methylated in >70{\%} of the cell lines. Epigenetic changes of four genes were detected in only small numbers of cell lines. None of the cell lines had methylation of the other seven genes analyzed. In primary neuroblastoma tumors, high-risk disease and poor outcome were associated with methylation of DCR2, CASP8, and HIN-1 individually. Although methylation of the other five individual genes was not predictive of poor outcome, a trend toward decreased survival was seen in patients with a methylation phenotype, defined as z4 methylated genes (P = 0.055). Conclusion: Our study indicates that clinically aggressive neuroblastoma tumors have aberrant methylation of multiple genes and provides a rationale for exploring treatment strategies that include demethylating agents.",
author = "Qiwei Yang and Kiernan, {Colleen M.} and Yufeng Tian and Salwen, {Helen R.} and Alexandre Chlenski and Brumback, {Babette A.} and London, {Wendy B.} and Cohn, {Susan L.}",
year = "2007",
month = "6",
day = "1",
doi = "10.1158/1078-0432.CCR-06-2846",
language = "English (US)",
volume = "13",
pages = "3191--3197",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "11",

}

TY - JOUR

T1 - Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome

AU - Yang, Qiwei

AU - Kiernan, Colleen M.

AU - Tian, Yufeng

AU - Salwen, Helen R.

AU - Chlenski, Alexandre

AU - Brumback, Babette A.

AU - London, Wendy B.

AU - Cohn, Susan L.

PY - 2007/6/1

Y1 - 2007/6/1

N2 - Purpose: Epigenetic aberrations have been shown to play an important role in the pathogenesis of most cancers. To investigate the clinical significance of epigenetic changes in neuroblastoma, we evaluated the relationship between clinicopathologic variables and the pattern of gene methylation in neuroblastoma cell lines and tumors. Experimental Design: Methylation-specific PCR was used to evaluate the gene methylation status of19 genes in14 neuroblastoma cell lines and 8 genes in 70 primary neuroblastoma tumors. Associations between gene methylation, established prognostic factors, and outcome were evaluated. Log-rank tests were used to identify the number of methylated genes that was most predictive of overall survival. Results: Epigenetic changes were detected in the neuroblastoma cell lines and primary tumors, although the pattern of methylation varied. Eight of the 19 genes analyzed were methylated in >70% of the cell lines. Epigenetic changes of four genes were detected in only small numbers of cell lines. None of the cell lines had methylation of the other seven genes analyzed. In primary neuroblastoma tumors, high-risk disease and poor outcome were associated with methylation of DCR2, CASP8, and HIN-1 individually. Although methylation of the other five individual genes was not predictive of poor outcome, a trend toward decreased survival was seen in patients with a methylation phenotype, defined as z4 methylated genes (P = 0.055). Conclusion: Our study indicates that clinically aggressive neuroblastoma tumors have aberrant methylation of multiple genes and provides a rationale for exploring treatment strategies that include demethylating agents.

AB - Purpose: Epigenetic aberrations have been shown to play an important role in the pathogenesis of most cancers. To investigate the clinical significance of epigenetic changes in neuroblastoma, we evaluated the relationship between clinicopathologic variables and the pattern of gene methylation in neuroblastoma cell lines and tumors. Experimental Design: Methylation-specific PCR was used to evaluate the gene methylation status of19 genes in14 neuroblastoma cell lines and 8 genes in 70 primary neuroblastoma tumors. Associations between gene methylation, established prognostic factors, and outcome were evaluated. Log-rank tests were used to identify the number of methylated genes that was most predictive of overall survival. Results: Epigenetic changes were detected in the neuroblastoma cell lines and primary tumors, although the pattern of methylation varied. Eight of the 19 genes analyzed were methylated in >70% of the cell lines. Epigenetic changes of four genes were detected in only small numbers of cell lines. None of the cell lines had methylation of the other seven genes analyzed. In primary neuroblastoma tumors, high-risk disease and poor outcome were associated with methylation of DCR2, CASP8, and HIN-1 individually. Although methylation of the other five individual genes was not predictive of poor outcome, a trend toward decreased survival was seen in patients with a methylation phenotype, defined as z4 methylated genes (P = 0.055). Conclusion: Our study indicates that clinically aggressive neuroblastoma tumors have aberrant methylation of multiple genes and provides a rationale for exploring treatment strategies that include demethylating agents.

UR - http://www.scopus.com/inward/record.url?scp=34250633589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250633589&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-06-2846

DO - 10.1158/1078-0432.CCR-06-2846

M3 - Article

VL - 13

SP - 3191

EP - 3197

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 11

ER -